Featuring

• [Moderator] Stacey McKenna, Resident Senior Fellow, Integrated Harm Reduction, R Street Institute

• Katharine Neill Harris, Ph.D., Alfred C. Glassell, III, Fellow in Drug Policy, Rice University’s Baker Institute for Public Policy

• Marianne Gibson, Program Director, Health, National Governors Association’s Center for Best Practicesn 

• Brigid K Groves, PharmD, Vice President, Professional Affairs, American Pharmacists Association

• Beth Dinges, PharmD, Harm Reduction Coordinator VA Illiana Health Care System in Danville, Illinois

Overview

Although fatalities have declined in recent years, drug overdose remains a top cause of preventable death in the United States. Naloxone is a safe, effective medication that reverses opioid overdoses and restores breathing within minutes. However, for this lifesaving tool to have population-level impact, people who use drugs—as well as their friends and loved ones and our communities at large—must have consistent, low-barrier access to affordable doses. While syringe services programs are the primary distributors of free and low-cost naloxone, pharmacies can fill availability gaps due to their extended hours and geographic ubiquity. 

Join us for a virtual panel discussion on overcoming challenges in the retail naloxone market.